nodes	percent_of_prediction	percent_of_DWPC	metapath
Clotiazepam—GABRR3—peripheral nervous system—Parkinson's disease	0.0252	0.0572	CbGeAlD
Clotiazepam—GABRR2—peripheral nervous system—Parkinson's disease	0.0219	0.0496	CbGeAlD
Clotiazepam—GABRR1—peripheral nervous system—Parkinson's disease	0.021	0.0477	CbGeAlD
Clotiazepam—GABRR3—nerve—Parkinson's disease	0.0197	0.0446	CbGeAlD
Clotiazepam—GABRR2—nerve—Parkinson's disease	0.017	0.0387	CbGeAlD
Clotiazepam—GABRR1—nerve—Parkinson's disease	0.0164	0.0372	CbGeAlD
Clotiazepam—GABRB2—hindbrain—Parkinson's disease	0.00752	0.0171	CbGeAlD
Clotiazepam—GABRA2—hindbrain—Parkinson's disease	0.00687	0.0156	CbGeAlD
Clotiazepam—GABRR1—forebrain—Parkinson's disease	0.00679	0.0154	CbGeAlD
Clotiazepam—GABRA1—hindbrain—Parkinson's disease	0.00664	0.0151	CbGeAlD
Clotiazepam—GABRD—forebrain—Parkinson's disease	0.0059	0.0134	CbGeAlD
Clotiazepam—GABRG1—forebrain—Parkinson's disease	0.00568	0.0129	CbGeAlD
Clotiazepam—GABRA5—forebrain—Parkinson's disease	0.00548	0.0124	CbGeAlD
Clotiazepam—GABRR3—head—Parkinson's disease	0.00466	0.0106	CbGeAlD
Clotiazepam—GABRR3—nervous system—Parkinson's disease	0.00442	0.01	CbGeAlD
Clotiazepam—GABRB2—brainstem—Parkinson's disease	0.00431	0.00978	CbGeAlD
Clotiazepam—GABRD—medulla oblongata—Parkinson's disease	0.00427	0.00968	CbGeAlD
Clotiazepam—GABRB2—forebrain—Parkinson's disease	0.00416	0.00944	CbGeAlD
Clotiazepam—GABRG2—forebrain—Parkinson's disease	0.00416	0.00944	CbGeAlD
Clotiazepam—GABRG1—medulla oblongata—Parkinson's disease	0.00411	0.00932	CbGeAlD
Clotiazepam—GABRG3—head—Parkinson's disease	0.00408	0.00926	CbGeAlD
Clotiazepam—GABRR2—head—Parkinson's disease	0.00404	0.00917	CbGeAlD
Clotiazepam—GABRB1—medulla oblongata—Parkinson's disease	0.00398	0.00903	CbGeAlD
Clotiazepam—GABRA2—brainstem—Parkinson's disease	0.00394	0.00893	CbGeAlD
Clotiazepam—GABRD—midbrain—Parkinson's disease	0.0039	0.00885	CbGeAlD
Clotiazepam—GABRR1—head—Parkinson's disease	0.00389	0.00883	CbGeAlD
Clotiazepam—GABRG3—nervous system—Parkinson's disease	0.00387	0.00878	CbGeAlD
Clotiazepam—GABRR2—nervous system—Parkinson's disease	0.00383	0.00869	CbGeAlD
Clotiazepam—GABRA1—brainstem—Parkinson's disease	0.00381	0.00863	CbGeAlD
Clotiazepam—GABRA2—forebrain—Parkinson's disease	0.0038	0.00862	CbGeAlD
Clotiazepam—GABRG1—midbrain—Parkinson's disease	0.00375	0.00852	CbGeAlD
Clotiazepam—GABRG3—central nervous system—Parkinson's disease	0.00373	0.00846	CbGeAlD
Clotiazepam—GABRR1—nervous system—Parkinson's disease	0.00369	0.00837	CbGeAlD
Clotiazepam—GABRA1—forebrain—Parkinson's disease	0.00367	0.00833	CbGeAlD
Clotiazepam—GABRG1—spinal cord—Parkinson's disease	0.00366	0.00831	CbGeAlD
Clotiazepam—GABRB1—midbrain—Parkinson's disease	0.00364	0.00826	CbGeAlD
Clotiazepam—GABRR2—cerebellum—Parkinson's disease	0.00361	0.00818	CbGeAlD
Clotiazepam—GABRR1—central nervous system—Parkinson's disease	0.00355	0.00806	CbGeAlD
Clotiazepam—GABRB1—spinal cord—Parkinson's disease	0.00355	0.00806	CbGeAlD
Clotiazepam—GABRD—head—Parkinson's disease	0.00338	0.00767	CbGeAlD
Clotiazepam—GABRG1—head—Parkinson's disease	0.00325	0.00738	CbGeAlD
Clotiazepam—GABRD—nervous system—Parkinson's disease	0.00321	0.00727	CbGeAlD
Clotiazepam—GABRB3—forebrain—Parkinson's disease	0.00319	0.00725	CbGeAlD
Clotiazepam—GABRB1—head—Parkinson's disease	0.00316	0.00716	CbGeAlD
Clotiazepam—GABRA5—head—Parkinson's disease	0.00314	0.00712	CbGeAlD
Clotiazepam—GABRD—central nervous system—Parkinson's disease	0.00309	0.007	CbGeAlD
Clotiazepam—GABRG1—nervous system—Parkinson's disease	0.00309	0.007	CbGeAlD
Clotiazepam—GABRD—cerebellum—Parkinson's disease	0.00302	0.00684	CbGeAlD
Clotiazepam—GABRB2—medulla oblongata—Parkinson's disease	0.00301	0.00682	CbGeAlD
Clotiazepam—GABRG2—medulla oblongata—Parkinson's disease	0.00301	0.00682	CbGeAlD
Clotiazepam—GABRB1—nervous system—Parkinson's disease	0.00299	0.00679	CbGeAlD
Clotiazepam—GABRA5—nervous system—Parkinson's disease	0.00298	0.00675	CbGeAlD
Clotiazepam—GABRG1—central nervous system—Parkinson's disease	0.00297	0.00674	CbGeAlD
Clotiazepam—GABRG3—brain—Parkinson's disease	0.00296	0.00671	CbGeAlD
Clotiazepam—GABRA3—head—Parkinson's disease	0.00292	0.00663	CbGeAlD
Clotiazepam—GABRG1—cerebellum—Parkinson's disease	0.0029	0.00659	CbGeAlD
Clotiazepam—GABRB1—central nervous system—Parkinson's disease	0.00288	0.00654	CbGeAlD
Clotiazepam—GABRA5—central nervous system—Parkinson's disease	0.00287	0.0065	CbGeAlD
Clotiazepam—GABRP—head—Parkinson's disease	0.00283	0.00641	CbGeAlD
Clotiazepam—GABRR1—brain—Parkinson's disease	0.00282	0.0064	CbGeAlD
Clotiazepam—GABRB1—cerebellum—Parkinson's disease	0.00282	0.00639	CbGeAlD
Clotiazepam—GABRA3—nervous system—Parkinson's disease	0.00277	0.00629	CbGeAlD
Clotiazepam—GABRB2—midbrain—Parkinson's disease	0.00275	0.00623	CbGeAlD
Clotiazepam—GABRG2—midbrain—Parkinson's disease	0.00275	0.00623	CbGeAlD
Clotiazepam—GABRG2—spinal cord—Parkinson's disease	0.00268	0.00608	CbGeAlD
Clotiazepam—GABRB2—spinal cord—Parkinson's disease	0.00268	0.00608	CbGeAlD
Clotiazepam—GABRA3—central nervous system—Parkinson's disease	0.00267	0.00605	CbGeAlD
Clotiazepam—GABRA1—medulla oblongata—Parkinson's disease	0.00265	0.00602	CbGeAlD
Clotiazepam—GABRD—brain—Parkinson's disease	0.00245	0.00556	CbGeAlD
Clotiazepam—GABRA1—midbrain—Parkinson's disease	0.00243	0.0055	CbGeAlD
Clotiazepam—GABRB2—head—Parkinson's disease	0.00238	0.0054	CbGeAlD
Clotiazepam—GABRG2—head—Parkinson's disease	0.00238	0.0054	CbGeAlD
Clotiazepam—GABRA1—spinal cord—Parkinson's disease	0.00237	0.00537	CbGeAlD
Clotiazepam—GABRG1—brain—Parkinson's disease	0.00236	0.00535	CbGeAlD
Clotiazepam—GABRB3—medulla oblongata—Parkinson's disease	0.00231	0.00524	CbGeAlD
Clotiazepam—GABRB1—brain—Parkinson's disease	0.00229	0.00519	CbGeAlD
Clotiazepam—GABRA5—brain—Parkinson's disease	0.00227	0.00516	CbGeAlD
Clotiazepam—GABRG2—nervous system—Parkinson's disease	0.00226	0.00512	CbGeAlD
Clotiazepam—GABRB2—nervous system—Parkinson's disease	0.00226	0.00512	CbGeAlD
Clotiazepam—GABRA2—head—Parkinson's disease	0.00218	0.00494	CbGeAlD
Clotiazepam—GABRB2—central nervous system—Parkinson's disease	0.00217	0.00493	CbGeAlD
Clotiazepam—GABRG2—central nervous system—Parkinson's disease	0.00217	0.00493	CbGeAlD
Clotiazepam—GABRE—head—Parkinson's disease	0.00216	0.0049	CbGeAlD
Clotiazepam—GABRB2—cerebellum—Parkinson's disease	0.00213	0.00482	CbGeAlD
Clotiazepam—GABRG2—cerebellum—Parkinson's disease	0.00213	0.00482	CbGeAlD
Clotiazepam—GABRA3—brain—Parkinson's disease	0.00212	0.0048	CbGeAlD
Clotiazepam—GABRB3—midbrain—Parkinson's disease	0.00211	0.00479	CbGeAlD
Clotiazepam—GABRA1—head—Parkinson's disease	0.0021	0.00477	CbGeAlD
Clotiazepam—GABRA2—nervous system—Parkinson's disease	0.00206	0.00468	CbGeAlD
Clotiazepam—GABRB3—spinal cord—Parkinson's disease	0.00206	0.00467	CbGeAlD
Clotiazepam—GABRE—nervous system—Parkinson's disease	0.00205	0.00464	CbGeAlD
Clotiazepam—GABRA1—nervous system—Parkinson's disease	0.00199	0.00452	CbGeAlD
Clotiazepam—GABRA2—central nervous system—Parkinson's disease	0.00199	0.00451	CbGeAlD
Clotiazepam—GABRE—central nervous system—Parkinson's disease	0.00197	0.00447	CbGeAlD
Clotiazepam—GABRA2—cerebellum—Parkinson's disease	0.00194	0.00441	CbGeAlD
Clotiazepam—GABRA1—central nervous system—Parkinson's disease	0.00192	0.00436	CbGeAlD
Clotiazepam—GABRA1—cerebellum—Parkinson's disease	0.00188	0.00426	CbGeAlD
Clotiazepam—CYP2B6—cardiovascular system—Parkinson's disease	0.00183	0.00415	CbGeAlD
Clotiazepam—GABRB3—head—Parkinson's disease	0.00183	0.00415	CbGeAlD
Clotiazepam—GABRB3—nervous system—Parkinson's disease	0.00173	0.00393	CbGeAlD
Clotiazepam—GABRB2—brain—Parkinson's disease	0.00173	0.00392	CbGeAlD
Clotiazepam—GABRG2—brain—Parkinson's disease	0.00173	0.00392	CbGeAlD
Clotiazepam—GABRB3—central nervous system—Parkinson's disease	0.00167	0.00379	CbGeAlD
Clotiazepam—GABRB3—cerebellum—Parkinson's disease	0.00163	0.0037	CbGeAlD
Clotiazepam—GABRA2—brain—Parkinson's disease	0.00158	0.00358	CbGeAlD
Clotiazepam—Clonazepam—CYP2E1—Parkinson's disease	0.00157	0.223	CrCbGaD
Clotiazepam—GABRE—brain—Parkinson's disease	0.00156	0.00355	CbGeAlD
Clotiazepam—GABRA1—brain—Parkinson's disease	0.00152	0.00346	CbGeAlD
Clotiazepam—GABRB3—brain—Parkinson's disease	0.00133	0.00301	CbGeAlD
Clotiazepam—Flunitrazepam—CYP2E1—Parkinson's disease	0.00126	0.179	CrCbGaD
Clotiazepam—CYP2B6—head—Parkinson's disease	0.00124	0.00281	CbGeAlD
Clotiazepam—CYP2B6—nervous system—Parkinson's disease	0.00118	0.00267	CbGeAlD
Clotiazepam—CYP2B6—central nervous system—Parkinson's disease	0.00113	0.00257	CbGeAlD
Clotiazepam—Flurazepam—CYP2E1—Parkinson's disease	0.00101	0.144	CrCbGaD
Clotiazepam—Midazolam—CYP2E1—Parkinson's disease	0.000936	0.133	CrCbGaD
Clotiazepam—CYP2B6—brain—Parkinson's disease	0.000899	0.00204	CbGeAlD
Clotiazepam—CYP3A4—nervous system—Parkinson's disease	0.000888	0.00201	CbGeAlD
Clotiazepam—CYP3A4—central nervous system—Parkinson's disease	0.000855	0.00194	CbGeAlD
Clotiazepam—Diazepam—CYP2E1—Parkinson's disease	0.000802	0.114	CrCbGaD
Clotiazepam—Flurazepam—ABCB1—Parkinson's disease	0.000529	0.0755	CrCbGaD
Clotiazepam—Midazolam—ABCB1—Parkinson's disease	0.000491	0.07	CrCbGaD
Clotiazepam—Diazepam—ABCB1—Parkinson's disease	0.00042	0.06	CrCbGaD
Clotiazepam—CYP2C19—Biological oxidations—MAOB—Parkinson's disease	0.000343	0.000621	CbGpPWpGaD
Clotiazepam—CYP2B6—Biological oxidations—CYP2D6—Parkinson's disease	0.000337	0.000611	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—ND3—Parkinson's disease	0.000337	0.00061	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—MCCC1—Parkinson's disease	0.000337	0.00061	CbGpPWpGaD
Clotiazepam—GABRG3—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000337	0.000609	CbGpPWpGaD
Clotiazepam—GABRA1—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000333	0.000603	CbGpPWpGaD
Clotiazepam—CYP2B6—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000333	0.000602	CbGpPWpGaD
Clotiazepam—GABRA1—Neuronal System—HSPA8—Parkinson's disease	0.000332	0.000601	CbGpPWpGaD
Clotiazepam—GABRB1—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000332	0.0006	CbGpPWpGaD
Clotiazepam—GABRA1—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000331	0.000599	CbGpPWpGaD
Clotiazepam—GABRA1—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000329	0.000596	CbGpPWpGaD
Clotiazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000325	0.000589	CbGpPWpGaD
Clotiazepam—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000321	0.000582	CbGpPWpGaD
Clotiazepam—GABRB2—Neuronal System—COMT—Parkinson's disease	0.000319	0.000578	CbGpPWpGaD
Clotiazepam—GABRB2—Neuronal System—MAOA—Parkinson's disease	0.000317	0.000574	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—OMD—Parkinson's disease	0.000317	0.000574	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—TALDO1—Parkinson's disease	0.000317	0.000574	CbGpPWpGaD
Clotiazepam—GABRA1—Neuronal System—DLG4—Parkinson's disease	0.000312	0.000564	CbGpPWpGaD
Clotiazepam—GABRA5—Neuronal System—COMT—Parkinson's disease	0.00031	0.000562	CbGpPWpGaD
Clotiazepam—CYP2B6—Biological oxidations—CYP2E1—Parkinson's disease	0.000308	0.000559	CbGpPWpGaD
Clotiazepam—GABRA5—Neuronal System—MAOA—Parkinson's disease	0.000308	0.000558	CbGpPWpGaD
Clotiazepam—GABRB2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000308	0.000557	CbGpPWpGaD
Clotiazepam—GABRR1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000305	0.000553	CbGpPWpGaD
Clotiazepam—GABRA1—Neuronal System—GRIN2B—Parkinson's disease	0.000305	0.000551	CbGpPWpGaD
Clotiazepam—GABRA3—Neuronal System—COMT—Parkinson's disease	0.000305	0.000551	CbGpPWpGaD
Clotiazepam—CYP2B6—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000304	0.000551	CbGpPWpGaD
Clotiazepam—GABRA3—Neuronal System—MAOA—Parkinson's disease	0.000302	0.000548	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—NDUFB11—Parkinson's disease	0.0003	0.000544	CbGpPWpGaD
Clotiazepam—GABRA1—Neuronal System—SLC6A3—Parkinson's disease	0.0003	0.000544	CbGpPWpGaD
Clotiazepam—GABRA2—Neuronal System—COMT—Parkinson's disease	0.000299	0.000542	CbGpPWpGaD
Clotiazepam—GABRA5—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000299	0.000542	CbGpPWpGaD
Clotiazepam—GABRB3—Neuronal System—COMT—Parkinson's disease	0.000297	0.000538	CbGpPWpGaD
Clotiazepam—GABRA2—Neuronal System—MAOA—Parkinson's disease	0.000297	0.000538	CbGpPWpGaD
Clotiazepam—GABRB3—Neuronal System—MAOA—Parkinson's disease	0.000295	0.000535	CbGpPWpGaD
Clotiazepam—GABRA3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000294	0.000532	CbGpPWpGaD
Clotiazepam—GABRR1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000293	0.000531	CbGpPWpGaD
Clotiazepam—GABRG2—Neuronal System—COMT—Parkinson's disease	0.000292	0.000529	CbGpPWpGaD
Clotiazepam—GABRR2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000291	0.000527	CbGpPWpGaD
Clotiazepam—GABRG2—Neuronal System—MAOA—Parkinson's disease	0.00029	0.000525	CbGpPWpGaD
Clotiazepam—GABRA2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000289	0.000523	CbGpPWpGaD
Clotiazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000288	0.000522	CbGpPWpGaD
Clotiazepam—GABRB3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000287	0.000519	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—GCH1—Parkinson's disease	0.000287	0.000519	CbGpPWpGaD
Clotiazepam—GABRB2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000283	0.000513	CbGpPWpGaD
Clotiazepam—GABRG2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000282	0.00051	CbGpPWpGaD
Clotiazepam—GABRR2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.00028	0.000506	CbGpPWpGaD
Clotiazepam—GABRA5—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000275	0.000498	CbGpPWpGaD
Clotiazepam—GABRA3—Transmembrane transport of small molecules—CP—Parkinson's disease	0.00027	0.000489	CbGpPWpGaD
Clotiazepam—GABRA2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000266	0.000481	CbGpPWpGaD
Clotiazepam—GABRB3—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000264	0.000478	CbGpPWpGaD
Clotiazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000264	0.000478	CbGpPWpGaD
Clotiazepam—GABRG2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000259	0.000469	CbGpPWpGaD
Clotiazepam—CYP2B6—Biological oxidations—COMT—Parkinson's disease	0.000256	0.000463	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—GBA—Parkinson's disease	0.000255	0.000463	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—DBH—Parkinson's disease	0.000255	0.000463	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—FBP1—Parkinson's disease	0.000255	0.000463	CbGpPWpGaD
Clotiazepam—GABRA1—Neuronal System—COMT—Parkinson's disease	0.000255	0.000462	CbGpPWpGaD
Clotiazepam—CYP2C19—Biological oxidations—CYP2D6—Parkinson's disease	0.000255	0.000461	CbGpPWpGaD
Clotiazepam—GABRR1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000255	0.000461	CbGpPWpGaD
Clotiazepam—CYP2B6—Biological oxidations—GSTP1—Parkinson's disease	0.000254	0.000461	CbGpPWpGaD
Clotiazepam—CYP2B6—Biological oxidations—MAOA—Parkinson's disease	0.000254	0.00046	CbGpPWpGaD
Clotiazepam—GABRA1—Neuronal System—MAOA—Parkinson's disease	0.000253	0.000459	CbGpPWpGaD
Clotiazepam—CYP2B6—Metapathway biotransformation—COMT—Parkinson's disease	0.000252	0.000456	CbGpPWpGaD
Clotiazepam—CYP2C19—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000251	0.000455	CbGpPWpGaD
Clotiazepam—CYP2B6—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000251	0.000454	CbGpPWpGaD
Clotiazepam—GABRA1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000246	0.000446	CbGpPWpGaD
Clotiazepam—GABRR1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000245	0.000443	CbGpPWpGaD
Clotiazepam—GABRR2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000243	0.00044	CbGpPWpGaD
Clotiazepam—GABRB3—BDNF signaling pathway—CASP3—Parkinson's disease	0.000242	0.000437	CbGpPWpGaD
Clotiazepam—GABRG3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.00024	0.000434	CbGpPWpGaD
Clotiazepam—GABRB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000236	0.000428	CbGpPWpGaD
Clotiazepam—CYP2B6—Biological oxidations—GSTM1—Parkinson's disease	0.000234	0.000423	CbGpPWpGaD
Clotiazepam—GABRR2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000233	0.000422	CbGpPWpGaD
Clotiazepam—CYP2C19—Biological oxidations—CYP2E1—Parkinson's disease	0.000233	0.000422	CbGpPWpGaD
Clotiazepam—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000231	0.000419	CbGpPWpGaD
Clotiazepam—CYP2B6—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000231	0.000417	CbGpPWpGaD
Clotiazepam—GABRG3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.00023	0.000417	CbGpPWpGaD
Clotiazepam—CYP2C19—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00023	0.000416	CbGpPWpGaD
Clotiazepam—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000228	0.000413	CbGpPWpGaD
Clotiazepam—GABRB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000227	0.000411	CbGpPWpGaD
Clotiazepam—GABRA1—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000226	0.00041	CbGpPWpGaD
Clotiazepam—GABRB3—BDNF signaling pathway—MAPK8—Parkinson's disease	0.000222	0.000402	CbGpPWpGaD
Clotiazepam—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000217	0.000393	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000213	0.000386	CbGpPWpGaD
Clotiazepam—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000206	0.000373	CbGpPWpGaD
Clotiazepam—GABRB2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000202	0.000366	CbGpPWpGaD
Clotiazepam—GABRG3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.0002	0.000362	CbGpPWpGaD
Clotiazepam—GABRB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000197	0.000357	CbGpPWpGaD
Clotiazepam—GABRA5—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000196	0.000355	CbGpPWpGaD
Clotiazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000195	0.000353	CbGpPWpGaD
Clotiazepam—GABRA1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000194	0.000352	CbGpPWpGaD
Clotiazepam—GABRB2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000194	0.000351	CbGpPWpGaD
Clotiazepam—CYP2C19—Biological oxidations—COMT—Parkinson's disease	0.000193	0.00035	CbGpPWpGaD
Clotiazepam—GABRA3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000193	0.000349	CbGpPWpGaD
Clotiazepam—CYP2C19—Biological oxidations—GSTP1—Parkinson's disease	0.000192	0.000348	CbGpPWpGaD
Clotiazepam—GABRG3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000192	0.000348	CbGpPWpGaD
Clotiazepam—CYP2C19—Biological oxidations—MAOA—Parkinson's disease	0.000192	0.000347	CbGpPWpGaD
Clotiazepam—CYP2C19—Metapathway biotransformation—COMT—Parkinson's disease	0.00019	0.000345	CbGpPWpGaD
Clotiazepam—CYP2C19—Metapathway biotransformation—GSTP1—Parkinson's disease	0.00019	0.000343	CbGpPWpGaD
Clotiazepam—GABRA2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000189	0.000343	CbGpPWpGaD
Clotiazepam—GABRB1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000189	0.000343	CbGpPWpGaD
Clotiazepam—GABRA5—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000188	0.000341	CbGpPWpGaD
Clotiazepam—GABRB3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000188	0.00034	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—DDC—Parkinson's disease	0.000187	0.00034	CbGpPWpGaD
Clotiazepam—GABRA3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000185	0.000335	CbGpPWpGaD
Clotiazepam—GABRG2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000185	0.000334	CbGpPWpGaD
Clotiazepam—GABRA2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000182	0.000329	CbGpPWpGaD
Clotiazepam—GABRB3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000181	0.000327	CbGpPWpGaD
Clotiazepam—GABRG2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000177	0.000321	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—GSTA4—Parkinson's disease	0.000177	0.000321	CbGpPWpGaD
Clotiazepam—CYP2C19—Biological oxidations—GSTM1—Parkinson's disease	0.000177	0.00032	CbGpPWpGaD
Clotiazepam—CYP2C19—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000174	0.000315	CbGpPWpGaD
Clotiazepam—GABRB2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000168	0.000305	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—MCCC1—Parkinson's disease	0.000166	0.0003	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—ND3—Parkinson's disease	0.000166	0.0003	CbGpPWpGaD
Clotiazepam—GABRA5—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000164	0.000296	CbGpPWpGaD
Clotiazepam—GABRB2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000162	0.000293	CbGpPWpGaD
Clotiazepam—GABRA1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000161	0.000292	CbGpPWpGaD
Clotiazepam—GABRA3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000161	0.000291	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—PLA2G6—Parkinson's disease	0.000159	0.000289	CbGpPWpGaD
Clotiazepam—GABRA2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000158	0.000286	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—MAOB—Parkinson's disease	0.000158	0.000286	CbGpPWpGaD
Clotiazepam—GABRA5—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000157	0.000284	CbGpPWpGaD
Clotiazepam—GABRB3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000157	0.000284	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—TALDO1—Parkinson's disease	0.000156	0.000282	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—OMD—Parkinson's disease	0.000156	0.000282	CbGpPWpGaD
Clotiazepam—GABRA1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000155	0.000281	CbGpPWpGaD
Clotiazepam—GABRA3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000154	0.000279	CbGpPWpGaD
Clotiazepam—GABRG2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000154	0.000279	CbGpPWpGaD
Clotiazepam—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000153	0.000277	CbGpPWpGaD
Clotiazepam—GABRA2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000152	0.000275	CbGpPWpGaD
Clotiazepam—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000151	0.000274	CbGpPWpGaD
Clotiazepam—GABRB3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000151	0.000273	CbGpPWpGaD
Clotiazepam—GABRG2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000148	0.000268	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—NDUFB11—Parkinson's disease	0.000148	0.000267	CbGpPWpGaD
Clotiazepam—GABRA1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000141	0.000256	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—GCH1—Parkinson's disease	0.000141	0.000255	CbGpPWpGaD
Clotiazepam—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.00014	0.000254	CbGpPWpGaD
Clotiazepam—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000138	0.00025	CbGpPWpGaD
Clotiazepam—GABRA1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000135	0.000244	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000133	0.000241	CbGpPWpGaD
Clotiazepam—GABRA1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000129	0.000234	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—FBP1—Parkinson's disease	0.000126	0.000227	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—GBA—Parkinson's disease	0.000126	0.000227	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—DBH—Parkinson's disease	0.000126	0.000227	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—ND3—Parkinson's disease	0.000125	0.000227	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—MCCC1—Parkinson's disease	0.000125	0.000227	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—OMD—Parkinson's disease	0.000118	0.000213	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—TALDO1—Parkinson's disease	0.000118	0.000213	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—CYP2D6—Parkinson's disease	0.000117	0.000212	CbGpPWpGaD
Clotiazepam—CYP3A4—Biological oxidations—COMT—Parkinson's disease	0.000116	0.00021	CbGpPWpGaD
Clotiazepam—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	0.000116	0.000209	CbGpPWpGaD
Clotiazepam—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	0.000115	0.000209	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—CTGF—Parkinson's disease	0.000115	0.000208	CbGpPWpGaD
Clotiazepam—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	0.000115	0.000207	CbGpPWpGaD
Clotiazepam—GABRA1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000114	0.000207	CbGpPWpGaD
Clotiazepam—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000114	0.000206	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	0.000112	0.000202	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—CYP2E1—Parkinson's disease	0.000107	0.000194	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—GCH1—Parkinson's disease	0.000106	0.000193	CbGpPWpGaD
Clotiazepam—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	0.000106	0.000192	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—NQO1—Parkinson's disease	0.000106	0.000192	CbGpPWpGaD
Clotiazepam—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000105	0.00019	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—TH—Parkinson's disease	0.000105	0.000189	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—CYCS—Parkinson's disease	0.0001	0.000182	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	9.6e-05	0.000174	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—GBA—Parkinson's disease	9.49e-05	0.000172	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—FBP1—Parkinson's disease	9.49e-05	0.000172	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—DBH—Parkinson's disease	9.49e-05	0.000172	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—DDC—Parkinson's disease	9.22e-05	0.000167	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—COMT—Parkinson's disease	8.89e-05	0.000161	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—GSTP1—Parkinson's disease	8.85e-05	0.00016	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—MAOA—Parkinson's disease	8.83e-05	0.00016	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—HMOX1—Parkinson's disease	8.72e-05	0.000158	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—GSTA4—Parkinson's disease	8.71e-05	0.000158	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—ABCB1—Parkinson's disease	8.37e-05	0.000152	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—GSTM1—Parkinson's disease	8.13e-05	0.000147	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—PLA2G6—Parkinson's disease	7.84e-05	0.000142	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—GPX1—Parkinson's disease	7.79e-05	0.000141	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—MAOB—Parkinson's disease	7.76e-05	0.000141	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—ND3—Parkinson's disease	7.53e-05	0.000136	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—MCCC1—Parkinson's disease	7.53e-05	0.000136	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—MTHFR—Parkinson's disease	7.18e-05	0.00013	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—TALDO1—Parkinson's disease	7.08e-05	0.000128	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—OMD—Parkinson's disease	7.08e-05	0.000128	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—DDC—Parkinson's disease	6.97e-05	0.000126	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	6.71e-05	0.000122	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—APOE—Parkinson's disease	6.69e-05	0.000121	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—GSTA4—Parkinson's disease	6.58e-05	0.000119	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	6.49e-05	0.000118	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—GCH1—Parkinson's disease	6.4e-05	0.000116	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	5.92e-05	0.000107	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—MAOB—Parkinson's disease	5.86e-05	0.000106	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—CYP2D6—Parkinson's disease	5.77e-05	0.000104	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—INS—Parkinson's disease	5.71e-05	0.000103	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—DBH—Parkinson's disease	5.71e-05	0.000103	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—GBA—Parkinson's disease	5.71e-05	0.000103	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—FBP1—Parkinson's disease	5.71e-05	0.000103	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—CTGF—Parkinson's disease	5.66e-05	0.000103	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	5.58e-05	0.000101	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—CYP2E1—Parkinson's disease	5.27e-05	9.55e-05	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—NQO1—Parkinson's disease	5.22e-05	9.44e-05	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—TH—Parkinson's disease	5.14e-05	9.31e-05	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—CYCS—Parkinson's disease	4.93e-05	8.94e-05	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—COMT—Parkinson's disease	4.37e-05	7.91e-05	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	4.36e-05	7.89e-05	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—GSTP1—Parkinson's disease	4.35e-05	7.88e-05	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—MAOA—Parkinson's disease	4.34e-05	7.86e-05	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—HMOX1—Parkinson's disease	4.29e-05	7.77e-05	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—CTGF—Parkinson's disease	4.28e-05	7.75e-05	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—DDC—Parkinson's disease	4.19e-05	7.59e-05	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—ABCB1—Parkinson's disease	4.12e-05	7.46e-05	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—GSTM1—Parkinson's disease	4e-05	7.24e-05	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	3.99e-05	7.22e-05	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—GSTA4—Parkinson's disease	3.96e-05	7.16e-05	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—NQO1—Parkinson's disease	3.94e-05	7.14e-05	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—TH—Parkinson's disease	3.88e-05	7.03e-05	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—GPX1—Parkinson's disease	3.83e-05	6.93e-05	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—CYCS—Parkinson's disease	3.73e-05	6.75e-05	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	3.56e-05	6.45e-05	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—MTHFR—Parkinson's disease	3.53e-05	6.4e-05	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—MAOB—Parkinson's disease	3.53e-05	6.39e-05	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—COMT—Parkinson's disease	3.3e-05	5.98e-05	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—APOE—Parkinson's disease	3.29e-05	5.96e-05	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—GSTP1—Parkinson's disease	3.29e-05	5.95e-05	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—MAOA—Parkinson's disease	3.28e-05	5.94e-05	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—HMOX1—Parkinson's disease	3.24e-05	5.87e-05	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—ABCB1—Parkinson's disease	3.11e-05	5.63e-05	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—GSTM1—Parkinson's disease	3.02e-05	5.47e-05	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—GPX1—Parkinson's disease	2.89e-05	5.24e-05	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—INS—Parkinson's disease	2.81e-05	5.09e-05	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—MTHFR—Parkinson's disease	2.67e-05	4.83e-05	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	2.62e-05	4.75e-05	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—CTGF—Parkinson's disease	2.57e-05	4.66e-05	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—APOE—Parkinson's disease	2.49e-05	4.5e-05	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	2.4e-05	4.34e-05	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—NQO1—Parkinson's disease	2.37e-05	4.29e-05	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—TH—Parkinson's disease	2.34e-05	4.23e-05	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—CYCS—Parkinson's disease	2.24e-05	4.06e-05	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—INS—Parkinson's disease	2.12e-05	3.84e-05	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—COMT—Parkinson's disease	1.99e-05	3.6e-05	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.98e-05	3.58e-05	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.97e-05	3.57e-05	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.95e-05	3.53e-05	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.87e-05	3.39e-05	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.82e-05	3.29e-05	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.74e-05	3.15e-05	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.61e-05	2.91e-05	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—APOE—Parkinson's disease	1.49e-05	2.71e-05	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—INS—Parkinson's disease	1.28e-05	2.31e-05	CbGpPWpGaD
